New Research Platform Seeks to Improve Collaboration Across COVID-19 Trials
The COVID-19 Collaboration Platform (COVIDCP), a new initiative from universities and clinical trial organizations across the U.S., will bring together research teams who are working on vaccines and treatments for COVID-19.
The research teams can share trial protocols and data, and aggregate and analyze evidence as well as receiving support for developing multisite trials, and free data storage and anonymization.
Partners of the 10-member COVIDCP include the Johns Hopkins Department of Biostatistics, the Harvard Data Science Institute, the International Forum for Acute Care Trialists (INFACT), Drexel University Dornsife School of Public Health, and the McGill Department of Epidemiology, Biostatistics and Occupational Health, among others.
Trials posted on the COVIDCP platform are open for collaboration. Learn more about COVIDCP here: https://bit.ly/2LcxyJk.